news_6

Coya Therapeutics, Inc. Announces an Agreement with Dr. Reddy’s Laboratories, Ltd. to License its proposed biosimilar Abatacept for the Development and Commercialization of COYA 302 for the Treatment of Neurodegenerative Diseases

logo-36

Malaysia Social Commerce Market Intelligence and Future Growth Dynamics Databook Q1 2023 Update: Sector to Reach $4.4 Billion by 2028 at a 21% CAGR – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Malaysia Social Commerce Market Intelligence and Future Growth Dynamics Databook - 50+ KPIs on Social Commerce Trends by...